Sanofi Company Top Insiders

SNYNF Stock  USD 95.42  2.10  2.15%   
Sanofi employs about 58 people. The company is managed by 10 executives with a total tenure of roughly 7 years, averaging almost 0.0 years of service per executive, having 5.8 employees per reported executive. Examination of Sanofi's management performance can provide insight into the company performance.
JeanBaptiste Chatillon  President
CFO, Executive Vice President Member of the Executive Committee
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanofi. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Sanofi Management Team Effectiveness

The company has return on total asset (ROA) of 0.0607 % which means that it generated a profit of $0.0607 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0959 %, meaning that it generated $0.0959 on every $100 dollars invested by stockholders. Sanofi's management efficiency ratios could be used to measure how well Sanofi manages its routine affairs as well as how well it operates its assets and liabilities.

Sanofi Workforce Comparison

Sanofi is currently regarded as top stock in number of employees category among its peers. The total workforce of Drug Manufacturers—General industry is at this time estimated at about 881,062. Sanofi adds roughly 58.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers—General industry.
The company has Profit Margin (PM) of 0.15 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.26 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.26.

Sanofi Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Sanofi Price Series Summation is a cross summation of Sanofi price series and its benchmark/peer.

Sanofi Notable Stakeholders

A Sanofi stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Sanofi often face trade-offs trying to please all of them. Sanofi's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Sanofi's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
JeanBaptiste ChatillonCFO, Executive Vice President Member of the Executive CommitteeProfile
Roy PapatheodorouGen VPProfile
Josephine FubaraChief CareProfile
Paul HudsonCEO DirectorProfile
Pierre ChancelSr MarketingProfile
Bruno MnardChief officerProfile
Laurent GilhodesPrincipal AccountingProfile
Dante BeccariaGlobal VPProfile
Eva SchaeferJansenHead RelationsProfile
Josep CatllaHead CommunicationsProfile

About Sanofi Management Performance

The success or failure of an entity such as Sanofi often depends on how effective the management is. Sanofi management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Sanofi management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Sanofi management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. Sanofi was founded in 1973 and is headquartered in Paris, France. Sanofi-Aventis operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 95442 people.

Sanofi Workforce Analysis

Traditionally, organizations such as Sanofi use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Sanofi within its industry.

Sanofi Manpower Efficiency

Return on Sanofi Manpower

Revenue Per Employee782.6M
Revenue Per Executive4.5B
Net Income Per Employee115.9M
Net Income Per Executive672M

Complementary Tools for Sanofi Pink Sheet analysis

When running Sanofi's price analysis, check to measure Sanofi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi is operating at the current time. Most of Sanofi's value examination focuses on studying past and present price action to predict the probability of Sanofi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi's price. Additionally, you may evaluate how the addition of Sanofi to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins